SCHEMBL6950282

SCHEMBL6950282

CCCC1=NN(c2ccncc2)C(=O)C1=CNc1ccccc1CC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.41
ALDH1A1 P00352 8/20 0.41
MAPT P10636 7/20 0.41
MEN1 O00255 6/20 0.41
POLB P06746 2/20 0.41
HTT P42858 1/20 0.41
KDM4E B2RXH2 4/20 0.39
MAPK1 P28482 3/20 0.39
THRB P10828 2/20 0.39
SAE1 Q9UBE0 1/20 0.39
UBA2 Q9UBT2 1/20 0.39
SHMT2 P34897 1/20 0.34
LMNA P02545 1/20 0.34
TDP1 Q9NUW8 2/20 0.33
HPGD P15428 2/20 0.33
TSHR P16473 1/20 0.33
PTGS1 P23219 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
KDR P35968 1/20 0.32
PTGS2 P35354 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6950276 1.00 KMT2A (0.41) KMT2AALDH1A1MAPTMEN1POLB
SCHEMBL8425736 0.95 KMT2A (0.38) KMT2AALDH1A1MAPTMEN1POLB
SCHEMBL8425734 0.95 KMT2A (0.38) KMT2AALDH1A1MAPTMEN1POLB
SCHEMBL6945065 0.89 ALDH1A1 (0.38) KMT2AALDH1A1MAPTMEN1POLB
SCHEMBL6945071 0.89 ALDH1A1 (0.38) KMT2AALDH1A1MAPTMEN1POLB
SCHEMBL6951666 0.88 KMT2A (0.43) KMT2AALDH1A1MAPTMEN1POLB
SCHEMBL6951671 0.88 KMT2A (0.43) KMT2AALDH1A1MAPTMEN1POLB
SCHEMBL8011308 0.86 KMT2A (0.41) KMT2AALDH1A1MAPTMEN1POLB
SCHEMBL6951564 0.86 KMT2A (0.41) KMT2AALDH1A1MAPTMEN1POLB
SCHEMBL6949466 0.85 MEN1 (0.53) KMT2AALDH1A1MAPTMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP claimed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP claimed
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed
US-5869516-A 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1999-02-09 US disclosed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP disclosed